Edarbi Articles
Takeda gets US regulatory backing for Edarbyclor
21 December 2011
Takeda’s Edarbi Oked in EU
12 December 2011
Takeda says Edarbi now available in USA; progresses pancreatic cancer drug into Ph III
18 April 2011
US FDA clears Takeda’s Edarbi for hypertension and grants full approval for GSK’s Promacta
28 February 2011
Showing 1-5 of 5 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
